» Articles » PMID: 35269412

T Lymphocyte and CAR-T Cell-Derived Extracellular Vesicles and Their Applications in Cancer Therapy

Overview
Journal Cells
Publisher MDPI
Date 2022 Mar 10
PMID 35269412
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EV) are a very diverse group of cell-derived vesicles released by almost all kind of living cells. EV are involved in intercellular exchange, both nearby and systemically, since they induce signals and transmit their cargo (proteins, lipids, miRNAs) to other cells, which subsequently trigger a wide variety of biological responses in the target cells. However, cell surface receptor-induced EV release is limited to cells from the immune system, including T lymphocytes. T cell receptor activation of T lymphocytes induces secretion of EV containing T cell receptors for antigen and several bioactive molecules, including proapoptotic proteins. These EV are specific for antigen-bearing cells, which make them ideal candidates for a cell-free, EV-dependent cancer therapy. In this review we examine the generation of EV by T lymphocytes and CAR-T cells and some potential therapeutic approaches of these EV.

Citing Articles

The multifaceted roles of extracellular vesicles for therapeutic intervention with non-Hodgkin lymphoma.

Lee A, Godwin A, Abdelhakim H Extracell Vesicles Circ Nucl Acids. 2024; 5(2):329-343.

PMID: 39639879 PMC: 11618822. DOI: 10.20517/evcna.2024.07.


Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities.

Li J, Zhou W, Wang H, Huang M, Deng H MedComm (2020). 2024; 5(12):e70019.

PMID: 39584047 PMC: 11586091. DOI: 10.1002/mco2.70019.


Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy.

Zhang S, Peng L, Chen Y, Xu Y, Moradi V Inflamm Regen. 2024; 44(1):45.

PMID: 39490997 PMC: 11533312. DOI: 10.1186/s41232-024-00358-x.


Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.

Bar O, Porgador A, Cooks T J Extracell Biol. 2024; 3(9):e70011.

PMID: 39328262 PMC: 11424882. DOI: 10.1002/jex2.70011.


Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression.

Tayanloo-Beik A, Eslami A, Sarvari M, Jalaeikhoo H, Rajaeinejad M, Nikandish M Oncol Rev. 2024; 18:1411736.

PMID: 39091989 PMC: 11291337. DOI: 10.3389/or.2024.1411736.


References
1.
Alonso R, Mazzeo C, Rodriguez M, Marsh M, Fraile-Ramos A, Calvo V . Diacylglycerol kinase α regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes. Cell Death Differ. 2011; 18(7):1161-73. PMC: 3131963. DOI: 10.1038/cdd.2010.184. View

2.
Ruella M, Xu J, Barrett D, Fraietta J, Reich T, Ambrose D . Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. Nat Med. 2018; 24(10):1499-1503. PMC: 6511988. DOI: 10.1038/s41591-018-0201-9. View

3.
Scott C, Vacca F, Gruenberg J . Endosome maturation, transport and functions. Semin Cell Dev Biol. 2014; 31:2-10. DOI: 10.1016/j.semcdb.2014.03.034. View

4.
Choudhuri K, Llodra J, Roth E, Tsai J, Gordo S, Wucherpfennig K . Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature. 2014; 507(7490):118-23. PMC: 3949170. DOI: 10.1038/nature12951. View

5.
Billadeau D, Nolz J, Gomez T . Regulation of T-cell activation by the cytoskeleton. Nat Rev Immunol. 2007; 7(2):131-43. DOI: 10.1038/nri2021. View